New ultrasound technique could map heart and brain arteries without radiation

NCT ID NCT07193225

Not yet recruiting Diagnosis Sponsor: French Cardiology Society Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new 3D ultrasound imaging method to map blood vessels in the heart and brain of people with atherosclerosis who are scheduled for carotid surgery. The goal is to see if this non-invasive, radiation-free technique can detect blockages and incomplete vessel networks as well as standard CT or MRI scans. Thirty-seven participants will receive an ultrasound contrast agent and undergo imaging before their surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SonoVue® (ultrasound contrast agent)
What this could lead to: If successful, this could provide a safer, non-invasive way to map blood vessels in the heart and brain, helping prevent complications during surgery.
What could go wrong: This is a small, early-stage study with only 37 participants, so results may not apply to everyone. The imaging technique is still experimental and may not be as accurate as standard methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAROTID ATHEROSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carotid artery disorder carotid stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CAROTID ATHEROSCLEROSIS

Contacts and locations

Locations

Georges Pompidou European Hospital

Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.